Man Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Man Group’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,374,470	Closed	-$54.1M	–	2243
2023 Q2	$54.1M	Buy	+1,374,470	New	+$48.5M	0.17%	132
2022 Q2	–	Hold	0	–	–	–	1882
2018 Q4	–	Sell	-166,344	Closed	-$393K	–	2170
2018 Q3	$393K	Sell	166,344 -15,000	-8%	-$37.4K	﹤0.01%	1889
2018 Q2	$495K	Sell	181,344 -2,700	-1%	-$7.45K	﹤0.01%	1814
2018 Q1	$504K	Buy	+184,044	New	+$533K	﹤0.01%	1715

Man Group's ISEE Position: Q3 2023 in Review

Man Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,374,470 shares — an estimated $54.1M sold.

Man Group first reported a position in ISEE in Q1 2018 and held it in 4 quarters. The position peaked at $54.1M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Man Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Man Group sold 1,374,470 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $54.1M.
Man Group first reported a position in IVERIC bio, Inc. Common Stock in Q1 2018 and held it in 4 quarters.
Man Group's IVERIC bio, Inc. Common Stock position peaked at $54.1M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Man Group's 13F filing for Q3 2023, filed 14 Nov 2023.